Alpelisib for PIK3CA-mutated advanced breast cancer

Jewel Park; Sang W. Shin

doi:10.1056/nejmc1907856

Alpelisib for PIK3CA-mutated advanced breast cancer

Jewel Park, Sang W. Shin

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	686
Number of pages	1
Journal	New England Journal of Medicine
Volume	381
Issue number	7
DOIs	https://doi.org/10.1056/nejmc1907856
Publication status	Published - 2019 Aug 15

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/nejmc1907856

Cite this

@article{b514a161c3bd47eaacd8d1c2d903689c,

title = "Alpelisib for PIK3CA-mutated advanced breast cancer",

author = "Jewel Park and Shin, {Sang W.}",

year = "2019",

month = aug,

day = "15",

doi = "10.1056/nejmc1907856",

language = "English",

volume = "381",

pages = "686",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Alpelisib for PIK3CA-mutated advanced breast cancer

AU - Park, Jewel

AU - Shin, Sang W.

PY - 2019/8/15

Y1 - 2019/8/15

UR - http://www.scopus.com/inward/record.url?scp=85071022969&partnerID=8YFLogxK

U2 - 10.1056/nejmc1907856

DO - 10.1056/nejmc1907856

M3 - Letter

C2 - 31412191

AN - SCOPUS:85071022969

SN - 0028-4793

VL - 381

SP - 686

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Alpelisib for PIK3CA-mutated advanced breast cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this